🌍 Advancing Global Health: Bharat Biotech to Supply GSK’s Malaria Vaccine to Gavi 🌍

Big news in global health: Bharat Biotech will supply the much-needed malaria vaccine developed by GSK to Gavi, the Vaccine Alliance, by 2026.

Why does this matter?

🔹 Gavi, established in 2000, is a global health partnership working to ensure equitable access to vaccines for children in the world’s poorest countries.

🔹 By delivering affordable vaccines to low-income regions, Gavi plays a crucial role in reducing child mortality and improving public health outcomes across parts of Africa and Asia.

🔹 Bharat Biotech’s involvement in the malaria vaccine initiative represents a significant step toward combating one of the world’s deadliest diseases, potentially saving hundreds of thousands of lives.

🔎 About Gavi

Gavi’s governance includes a Secretariat handling daily operations and a Board making strategic decisions.

Permanent seats on the Board are held by UNICEF, WHO, the World Bank, and the Bill & Melinda Gates Foundation, ensuring strong collaboration between global health leaders.

Two-thirds of Gavi’s voting members represent alliance partners, while one-third are independent, ensuring balanced, effective decision-making.

This partnership reflects how innovation and international cooperation can come together to address some of the toughest global health challenges. It’s a reminder of the power of public-private partnerships in making healthcare accessible to all.

#GlobalHealth #Vaccines #Malaria #BharatBiotech #Gavi #PublicHealth #HealthcareEquity